Clinical trial Recruiting at 1 site Observational Ages 18 to 70

HbA1c and stomach emptying before anesthesia measured by gastric ultrasound

Official title: Evaluation of the Effect of Hemoglobin A1c Levels on Gastric Emptying Assessed by Gastric Ultrasound

Run by Kutahya Health Sciences University · NCT07375680 · Data updated 2026-11-12

This study will test whether adults having elective surgery with higher HbA1c have slower stomach emptying before general anesthesia.

More Diabetes Mellitus trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment134 (estimated)
SponsorKutahya Health Sciences University
Academic / other
Locations1 site (Kütahya, Kütahya)
StatusRecruiting
StartedFebruary 15, 2026
Main results expectedAugust 15, 2026
Study endsSeptember 2026
Registry record updatedApril 8, 2026
Trial IDNCT07375680 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–70 scheduled for elective surgery under general anesthesia who can provide informed consent and do not have prior gastric surgery or neuromuscular disease.

Probably not a fit

Patients undergoing emergency surgery, pregnant patients, or those currently using opioids or anticholinergic medications may not benefit from the study or be eligible to participate.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will use bedside gastric ultrasonography to measure antral cross-sectional area and estimate gastric volume in adults scheduled for elective surgery after standard fasting. Participants aged 18–70 with ASA physical status I–III will have a preoperative gastric ultrasound performed by trained anesthesiologists and their recent HbA1c values recorded from preoperative labs. Gastric ultrasound measurements and estimated gastric volumes will be compared across different HbA1c levels. Demographic, anthropometric, fasting duration, and clinical data will be collected for secondary analyses exploring factors associated with delayed gastric emptying.

Why it matters

Potential benefit: If successful, the findings could help clinicians better identify patients at higher risk of pulmonary aspiration and tailor anesthetic management based on HbA1c.

How similar studies have gone: Prior studies have linked diabetes and poor long-term glycemic control to delayed gastric emptying, but applying preoperative gastric ultrasound specifically in relation to HbA1c among surgical patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18 to 70 years. ASA physical status I-III. Scheduled for elective surgery under general anesthesia. Ability to provide written informed consent.

Exclusion Criteria:

Scheduled for emergency surgery. Refusal or inability to provide informed consent. Pregnancy. Age \<18 years or \>70 years. History of gastric surgery. Neuromuscular disease. Current use of opioid or anticholinergic medications.

Where it's running

  • Kutahya Health Science University Training and Research Hospital
    Kütahya, Kütahya, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: merve yaman, MD, Assistant Professor — Kutahya Health Science University
  • Study coordinator: merve yaman, MD, Assistant Professor
  • Email: merve.yaman@ksbu.edu.tr
  • Phone: +905363794742

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.